Stockreport

Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $1.43 per share versus the Zacks Consensus Estimate of a loss of $0.98. This compares to a loss of [Read more]